arrow
B

Bruna Gigante

eberhard-karls-university of tubingen
H指数:57
被引数:5.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome-wide association study of image-based emphysema scoring in the Swedish CArdioPulmonary bioImage Study (SCAPIS) suggests two new risk loci in smokers

基于图像的肺气肿评分在全基因组关联研究中发现了两个新的吸烟者风险位点(瑞典CArdioPulmonary bioImage Study, SCAPIS)

2026-08-080
OAAI
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks

经皮冠状动脉介入治疗后急性冠状动脉综合征患者二级预防的抗血栓治疗:个性化选择以减少出血或缺血风险

2026-04-011
PRE
Non-visualization of the inferior thyroid arteries on B-mode ultrasound is associated with structural inferior thyroid artery abnormalities and an adverse vascular phenotype

甲状腺下动脉在B模式超声下的不可见性与结构异常及不良血管表型相关

2026-01-010
OAAI
Enhancing Cardiovascular Risk Prediction with a Simplified Carotid IMT Protocol: Evidence from the IMPROVE Study
2025-02-260
OAAI
Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis

脂蛋白和脂蛋白脂质组成与血糖异常和亚临床冠状动脉粥样硬化的阶段有关

2025-01-011
PRE
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
2024-09-054
PRE
Determinants of Carotid Wall Echolucency in a Cohort of European High Cardiovascular Risk Subjects: A Cross-Sectional Analysis of IMPROVE Baseline Data
2024-03-262
OAAI
Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease: Pooled De Novo Results From 15 Observational Studies

多不饱和脂肪在改变与心血管疾病家族史相关的心血管风险中的作用: 来自15项观察性研究的从头汇总结果

2024-01-231
OAAI
Pulmonary function and atherosclerosis in the general population: causal associations and clinical implications
2024-01-021
OAAI
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
2023-07-139
OA